Atlas Trials

Role of Nebulized Dexmedetomidine in Blunting the Effects of Direct Laryngoscopy and Endotracheal Tube on Heart Rate and Blood Pressure.

Clinical trial NCT06103721 · UNKNOWN

Trial details

NCT number
NCT06103721
Sponsor
Muhammad Haroon Anwar
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hemodynamic Instability
Start date
2023-11-21
Primary completion
2024-12-01
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.